175 related articles for article (PubMed ID: 7620113)
1. Levels of vitamin K, immunoreactive prothrombin, des-gamma-carboxy prothrombin and gamma-glutamyl carboxylase activity in hepatocellular carcinoma tissue.
Yamagata H; Nakanishi T; Furukawa M; Okuda H; Obata H
J Gastroenterol Hepatol; 1995; 10(1):8-13. PubMed ID: 7620113
[TBL] [Abstract][Full Text] [Related]
2. Measurement of immunoreactive prothrombin, des-gamma-carboxy prothrombin, and vitamin K in human liver tissues: overproduction of immunoreactive prothrombin in hepatocellular carcinoma.
Ono M; Ohta H; Ohhira M; Sekiya C; Namiki M
Am J Gastroenterol; 1990 Sep; 85(9):1149-54. PubMed ID: 1697141
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of the abnormal vitamin K-dependent gamma-carboxylation process in human hepatocellular carcinomas.
Huisse MG; Leclercq M; Belghiti J; Flejou JF; Suttie JW; Bezeaud A; Stafford DW; Guillin MC
Cancer; 1994 Sep; 74(5):1533-41. PubMed ID: 7520347
[TBL] [Abstract][Full Text] [Related]
4. Measurement of immunoreactive prothrombin precursor and vitamin-K-dependent gamma-carboxylation in human hepatocellular carcinoma tissues: decreased carboxylation of prothrombin precursor as a cause of des-gamma-carboxyprothrombin synthesis.
Ono M; Ohta H; Ohhira M; Sekiya C; Namiki M
Tumour Biol; 1990; 11(6):319-26. PubMed ID: 2173855
[TBL] [Abstract][Full Text] [Related]
5. Cytoskeletal changes during epithelial-to-fibroblastoid conversion as a crucial mechanism of des-gamma-carboxy prothrombin production in hepatocellular carcinoma.
Murata K; Suzuki H; Okano H; Oyamada T; Yasuda Y; Sakamoto A
Int J Oncol; 2009 Nov; 35(5):1005-14. PubMed ID: 19787254
[TBL] [Abstract][Full Text] [Related]
6. Production of abnormal prothrombin (des-gamma-carboxy prothrombin) by hepatocellular carcinoma. A clinical and experimental study.
Okuda H; Obata H; Nakanishi T; Furukawa R; Hashimoto E
J Hepatol; 1987 Jun; 4(3):357-63. PubMed ID: 3036940
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-induced des-gamma-carboxy prothrombin production in hepatocellular carcinoma.
Murata K; Suzuki H; Okano H; Oyamada T; Yasuda Y; Sakamoto A
Int J Oncol; 2010 Jan; 36(1):161-70. PubMed ID: 19956845
[TBL] [Abstract][Full Text] [Related]
8. Changes of plasma des-gamma-carboxy prothrombin levels in patients with hepatocellular carcinoma in response to vitamin K.
Furukawa M; Nakanishi T; Okuda H; Ishida S; Obata H
Cancer; 1992 Jan; 69(1):31-8. PubMed ID: 1309308
[TBL] [Abstract][Full Text] [Related]
9. Des-gamma-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review.
Weitz IC; Liebman HA
Hepatology; 1993 Oct; 18(4):990-7. PubMed ID: 8406374
[TBL] [Abstract][Full Text] [Related]
10. Measurement of des-gamma-carboxy prothrombin levels in cancer and non-cancer tissue in patients with hepatocellular carcinoma.
Yuan LW; Tang W; Kokudo N; Sugawara Y; Karako H; Hasegawa K; Aoki T; Kyoden Y; Deli G; Li YG; Makuuchi M
Oncol Rep; 2004 Aug; 12(2):269-73. PubMed ID: 15254687
[TBL] [Abstract][Full Text] [Related]
11. Exon 2 deletion splice variant of gamma-glutamyl carboxylase causes des-gamma-carboxy prothrombin production in hepatocellular carcinoma cell lines.
Ueda N; Shiraha H; Fujikawa T; Takaoka N; Nakanishi Y; Suzuki M; Matsuo N; Tanaka S; Nishina S; Uemura M; Takaki A; Shiratori Y; Yamamoto K
Mol Oncol; 2008 Oct; 2(3):241-9. PubMed ID: 19383345
[TBL] [Abstract][Full Text] [Related]
12. A study about mechanisms of des-gamma-carboxy prothrombin's production in hepatocellular carcinoma.
Bertino G; Ardiri AM; Boemi PM; Ierna D; Interlandi D; Caruso L; Minona E; Trovato MA; Vicari S; Li Destri G; Puleo S
Panminerva Med; 2008 Sep; 50(3):221-6. PubMed ID: 18927526
[TBL] [Abstract][Full Text] [Related]
13. Plasma abnormal prothrombin (des-gamma-carboxy prothrombin) as a marker of hepatocellular carcinoma.
Fujiyama S; Morishita T; Hashiguchi O; Sato T
Cancer; 1988 Apr; 61(8):1621-8. PubMed ID: 2450634
[TBL] [Abstract][Full Text] [Related]
14. Vitamin K2 inhibits the growth of hepatocellular carcinoma via decrease of des-gamma-carboxy prothrombin.
Ma M; Qu XJ; Mu GY; Chen MH; Cheng YN; Kokudo N; Tang W; Cui SX
Chemotherapy; 2009; 55(1):28-35. PubMed ID: 18974646
[TBL] [Abstract][Full Text] [Related]
15. Impairment of clathrin-mediated endocytosis via cytoskeletal change by epithelial to fibroblastoid conversion in HepG2 cells: a possible mechanism of des-gamma-carboxy prothrombin production in hepatocellular carcinoma.
Murata K; Sakamoto A
Int J Oncol; 2008 Dec; 33(6):1149-55. PubMed ID: 19020747
[TBL] [Abstract][Full Text] [Related]
16. Phenotype-dependent production of des-γ-carboxy prothrombin in hepatocellular carcinoma.
Suzuki H; Murata K; Gotoh T; Kusano M; Okano H; Oyamada T; Yasuda Y; Imamura M; Kudo M; Mizokami M; Sakamoto A
J Gastroenterol; 2011 Oct; 46(10):1219-29. PubMed ID: 21744129
[TBL] [Abstract][Full Text] [Related]
17. Significance of des-gamma-carboxy prothrombin production in hepatocellular carcinoma.
Fujikawa T; Shiraha H; Yamamoto K
Acta Med Okayama; 2009 Dec; 63(6):299-304. PubMed ID: 20035286
[TBL] [Abstract][Full Text] [Related]
18. Specificity of increased des-gamma-carboxyprothrombin in hepatocellular carcinoma after vitamin K1 injection.
Lefrère JJ; Gozin D; Soulier JP; Bettan L; Mavier P; Dhumeaux D; Guillaumont M; Leclercq M
J Hepatol; 1987 Aug; 5(1):27-9. PubMed ID: 2821104
[TBL] [Abstract][Full Text] [Related]
19. The role of des-gamma-carboxy prothrombin levels in hepatocellular carcinoma and liver tissues.
Shimada M; Yamashita Y; Hamatsu T; Hasegawa H; Utsunomiya T; Aishima S; Sugimachi K
Cancer Lett; 2000 Oct; 159(1):87-94. PubMed ID: 10974410
[TBL] [Abstract][Full Text] [Related]
20. Des-γ-carboxy prothrombin (DCP) as a potential autologous growth factor for the development of hepatocellular carcinoma.
Zhang YS; Chu JH; Cui SX; Song ZY; Qu XJ
Cell Physiol Biochem; 2014; 34(3):903-15. PubMed ID: 25200250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
